Navigation Links
Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc
Date:8/5/2008

WHIPPANY, N.J., Aug. 5 /PRNewswire/ -- Nexgen Spine, a leading developer of innovative spinal implants for the surgical treatment of degenerative disc disease, announced today that it has received CE mark approval to market the Physio-L(R) Lumbar Artificial Disc in the European Union.

"We are delighted that the Physio-L(R) Artificial Disc Prosthesis has received CE mark approval," said Alastair Clemow, Ph.D., President and CEO of Nexgen Spine. "This represents an important milestone in our plan to launch a full range of artificial disc prostheses based on our proprietary elastomeric disc technology." Dr. Clemow further added, "the fact that the Physio-L(R) is the first of the next generation elastomeric lumbar discs to receive a CE mark makes this approval even more exciting."

The Physio-L(R) Artificial Disc is an elastomeric disc prosthesis designed to be used in the lumbar spine for patients suffering from degenerative disc disease. The device's proprietary elastomeric technology enables the disc to closely mimic the mechanical properties of the natural disc and represents a significant advance over current designs of disc prostheses.

"The unique properties of the Physio-L(R) help restore the natural shock absorption of the disc," said Casey Lee MD, Chairman and Founder of Nexgen Spine. "This allows the surgeon to restore function to the patient's disc. The clinical data for the Physio-L(R) are demonstrating outstanding improvements in both patient disability and pain, supporting the concept of using elastomeric polymers for total disc prostheses."

Nexgen Spine, Inc. is dedicated to providing its customers with high quality products that promote pain relief, preservation of motion and restoration of function by applying state-of-the-art design, biomaterials, and manufacturing technology. The company, based in Whippany NJ, is ISO 13485:2003 certified.

Contact: Alastair Clemow, President & CEO at 973-386-1800 ext 302 (aclemow@nexgenspine.com)


'/>"/>
SOURCE Nexgen Spine
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
2. Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
3. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
4. CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
5. SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver
6. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
7. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
8. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
9. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
10. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
11. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that Frost & ... Innovation Award for Its fibromyalgia pain management device. The ... market research by Frost & Sullivan,s industry experts. ... product, the AVACEN 100, offers a safe and effective solution ... ...
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve ... engagement.” The patient is doing more than filling out a survey; in many cases ... an increasing emphasis in health care and research on the importance of active engagement ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
Breaking Medicine News(10 mins):